|Adult ADHD Home||Succeed at Work||ADHD Self Test|
|Love & Friendships||Manage Time & Money||ADHD Adult Blogs|
|The Organized Life||Stress, Sleep, Health||Adult Support Groups|
|Apps & Gadgets||Inspirational Stories||Expert Answers|
|ADHD Parenting Home||Schedules & Time||Sample Routines|
|Discipline & Behavior||Teens & Young Adults||Parent Support Group|
|ADHD Parenting Skills||Nutrition & Diet||Parenting Blogs|
|Friendships & Social Skills||Sports & Hobbies||Summer & Camps|
|ADHD Treatment Home||ADHD Medications||Medication Reviews||Adderall|
|Treating Your Child||Nutrition & Diet||Fish Oil Printable||Daytrana|
|Expert Q&As||Non-Medical Treatment||Find Professionals||Strattera|
|Behavior Therapy||Brain Training||Quillivant XR||Vyvanse|
|ADHD/LD School Home||High School & College||Accommodations|
|IEPs & 504s||ADHD Study Skills||ADHD School Guide|
|Working with School||School Organization Help||College Survival Guide|
|Social Skills at School||For Teachers Only||Is it LD? A Self Test|
|ADHD Diagnosis Home||ADHD & Women||Is it ADHD? Self Tests|
|Getting a Diagnosis||Is it a Related Condition?||Medical Q&As|
|ADHD Symptoms||Post Diagnosis Next Steps||Myths & Realities|
|Is it Learning Disabilities?||ADHD Treatment||ADHD Support Groups|
|Tools and Checklists|
|ADHD Topics A-Z|
|Share Your Story|
|Give a Gift|
|Buy Back Issues|
Modafinil Leads to Significant Improvement in Some Subtypes of ADHD
New research provides evidence that Modafinil can greatly improve symptoms in children with inattentive or combined type ADHD.
Wednesday February 20th - 10:58am
Researchers at Massachusetts General Hospital in Boston have found evidence supporting the use of Modafinil in the treatment of children with inattentive type or combined types ADHD. Modafinil, marketed under the brand name Provigil, is a psychostimulant that may cause less anxiety, excessive motor activity, and "jitteriness" than traditional stimulants.
The current research used 3 double-blind placebo studies, meaning that in each study neither the participants themselves nor those treating them knew whether they were taking the medication or a placebo. The study participants included children aged six- to 17-years-old and included children diagnosed with each of the three subtypes of ADHD.
Questionnaires to measure the functioning of each child were administered to parents, teachers, and clinicians after 7 to 9 weeks. Children with inattentive or combined types of ADHD showed significant improvements in symptoms and functioning both at home and school, providing evidence that Modafinil may be an effective treatment for children with these subtypes.